Navigation Links
Association of Clinical Research Organizations (ACRO) Names Dr. Derek Winstanly Chair-Elect
Date:7/10/2008

WASHINGTON, July 10 /PRNewswire-USNewswire/ -- The Association of Clinical Research Organizations (ACRO), which represents the clinical outsourcing industry to regulators, biopharmaceutical clients, policy makers and the public in the U.S. and worldwide, recently announced the election of Dr. Derek Winstanly as Chair-Elect of the association.

Derek Winstanly, MBChB, Executive Vice President of Strategic Business Partnerships for Quintiles Transnational, was appointed the 2008 Chair-Elect in June. Dr. Winstanly is a respected leader of the clinical research organization (CRO) industry, having held various global leadership positions within Quintiles since joining the company in 1999. In his current role, he works with senior biopharmaceutical executives to provide long-term strategic solutions, and is responsible for the Office of the Chief Medical Officer as well as the ethics and quality assurance functions of the company.

"I congratulate Dr. Winstanly on his appointment as Chair-Elect of ACRO," said David Spaight, ACRO Chair and President of MDS Pharma Services. "His experience and insight will enhance the association's efforts to demonstrate the important contributions that CROs make to the clinical research enterprise."

"I am pleased to join the leadership of ACRO at a time of extraordinary growth for our industry," added Dr. Winstanly. "I look forward to driving the association's efforts to increase public understanding about the vital role CROs play in the conduct of safe and high-quality clinical studies to accelerate the development of new medical treatments."

About ACRO

The Association of Clinical Research Organizations (ACRO) is the professional organization of companies whose focus is clinical research. The association provides an active voice for the CRO industry, which provides specialized services that are integral to the development of drugs, biologics and medical devices. ACRO helps its members improve the quality, efficiency and safety of biomedical research. For more information, please visit HYPERLINK "http://www.acrohealth.org/" http://www.acrohealth.org.


'/>"/>
SOURCE Association of Clinical Research Organizations
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Kendle Experts to Present at the Drug Information Association 44th Annual Meeting
2. Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
3. Genaera Corporation Presents Additional Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at American Diabetes Association
4. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
5. Grocery Manufacturers Association: Study Signals Progress in Battle Against Obesity
6. CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting
7. Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting
8. Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association
9. Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting
10. Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidones Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events
11. Association of Clinical Research Organizations (ACRO) to Help Lead Clinical Trials Transformation Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... VIEJO , Kalifornien, 12. Februar 2016 /PRNewswire/ ... mit der Aufnahme von Patienten für eine Studie ... von Aneurysmen („WEB") speziell für die Behandlung von ... Spelle , MD, Leiter der Neuroradiologie an der ... Frankreich, und Hauptprüfarzt der CLARYS-Studie hat den ersten ...
(Date:2/12/2016)... ALISO VIEJO, Calif. , Feb. 12, 2016 /PRNewswire/ ... patient enrollment in a study to evaluate the safety ... specifically for the treatment of ruptured intracranial aneurysms.  Prof ... Bicetre University Hospital, in Paris, France ... the first patient. France ...
(Date:2/12/2016)... and SEOUL, South Korea ... Biosys­tems Menarini and Macrogen, Inc. today announced they ... and innovative procedures for precision medicine in cancer. ... Silicon Biosystems, DEPArray™ digital-sorting technology with Macrogen,s high-throughput ... tests certified under the Clinical Laboratory Improvement Amendments ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... February 13, 2016 , ... The producers of ... American businesses. , The increasingly modern world of instantaneous consumption proves very convenient ... energy sources such as oil and coal, which pollutes our air, water, and soil. ...
(Date:2/13/2016)... ... ... In the early or “honeymoon” stage of a relationship, couples strive to ... way to be romantic, and may exaggerate a strength or two in an effort ... , A recent study from Queendom.com , however, suggests that new couples ...
(Date:2/12/2016)... Opelousas, LA (PRWEB) , ... February 12, 2016 , ... ... of St. Landry and Evangeline Parishes. The purpose of these scholarships is to ... to encourage those individuals to seek employment within these two parishes. , “We ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... 2016 — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... life cycle of pharmaceutical products, garnering increased attention from all stakeholders in the ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... nominations have closed for the ISE Southeast Awards 2016. Finalists and winners of ... the ISE® Southeast Executive Forum and Awards Gala on March 15, 2016 at ...
Breaking Medicine News(10 mins):